Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

NCT04657666 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity in Participants With Multiple Sclerosis

Interventions

DRUG: Nabiximols
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals